Log In
Print
BCIQ
Print
Print this Print this
 

esketamine

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionNMDA receptor antagonist
Molecular Target NMDA receptor
Mechanism of ActionNMDA receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDepression
Indication DetailsTreat major depression; Treat treament-resistant depression
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today